about
Endoscopic retrograde cholangiopancreaticography with or without stenting in patients with pancreaticobiliary malignancy, prior to surgeryEndoscopic retrograde cholangiopancreaticography with or without stenting in patients with pancreaticobiliary malignancy, prior to surgerySystematic review with network meta-analysis: adjuvant therapy for resected biliary tract cancerThe effect of preoperative chemotherapy treatment in surgically treated intrahepatic cholangiocarcinoma patients-A multi-institutional analysis.Diagnostic performance of contrast enhanced CT and 18F-FDG PET/CT in suspicious recurrence of biliary tract cancer after curative resection.Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancerA phase I study for adjuvant chemotherapy of gemcitabine plus S-1 in curatively resected patients with biliary tract cancer: adjusting the dose of adjuvant chemotherapy according to the surgical procedures.Reduced EBP50 expression levels are correlated with unfavorable clinicopathological features of extrahepatic bile duct carcinoma and promote the proliferation and migration of QBC939 cells.In-hospital mortality after resection of biliary tract cancer in the United States.Benefit of neoadjuvant concurrent chemoradiotherapy for locally advanced perihilar cholangiocarcinomaChemotherapy and targeted therapy for gall bladder cancer.Metastatic lymph nodes in hilar cholangiocarcinoma: does size matter?Early bile duct cancer.Post-operative morbidity results in decreased long-term survival after resection for hilar cholangiocarcinoma.Surgical strategy for bile duct cancer: Advances and current limitations.A new clinically based staging system for perihilar cholangiocarcinoma.Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer.Clinical features and survival outcome of locally advanced extrahepatic cholangiocarcinomaSWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma.Prognostic Role of Mucin Antigen MUC4 for Cholangiocarcinoma: A Meta-Analysis.Long-term survival in hilar cholangiocarcinoma also possible in unresectable patients.The safety and efficacy of nasobiliary drainage versus biliary stenting in malignant biliary obstruction: A systematic review and meta-analysis.Is an aggressive surgical approach worthwhile in biliary cancer?Concomitant dysregulation of microRNAs miR-151-3p and miR-126 correlates with improved survival in resected cholangiocarcinoma.Surgery for extrahepatic cholangiocarcinoma: predictors of survival.Management of hilar biliary strictures.Radiation therapy, chemotherapy and chemoradiation in hilar cholangiocarcinoma.ACS-NSQIP has the potential to create an HPB-NSQIP option.Cholangiocarcinoma: a 7-year experience at a single center in Greece.Multimodality therapy for locoregional extrahepatic cholangiocarcinoma: a population-based analysis.Postoperative radiotherapy appeared to improve the disease free survival rate of patients with extrahepatic bile duct cancer at high risk of loco-regional recurrence.Intrahepatic cholangiocarcinoma: current perspectives.Trend analysis and survival of primary gallbladder cancer in the United States: a 1973-2009 population-based study.Evidence-based decompression in malignant biliary obstruction.Hilar cholangiocarcinoma: expert consensus statement.Multimodality treatment of intrahepatic cholangiocarcinoma: A review.Cholangiocarcinoma: classification, diagnosis, staging, imaging features, and management.A Comparison of Prognostic Schemes for Perihilar CholangiocarcinomaConditional probability of long-term survival after resection of hilar cholangiocarcinoma.A long-term survivor of hilar cholangiocarcinoma with resection of recurrent peritoneal dissemination after R0 surgery: a case report.
P2860
Q24244039-9D446F76-B2EE-470E-8B09-DEBEDA4DABEBQ24244362-1EDDB989-4974-4AF3-BF9A-D67EDBE82DEAQ26864932-D92BE3C8-DB1F-4E21-9C5B-E92EB29B7403Q30274956-7D18EBD2-DA07-4C23-BB1D-8851C984B1E0Q31014798-1DADF333-89BA-4C0D-B5DF-16FEDB2C760DQ33372640-48DFC2FF-36C6-415D-BB4E-FCA5A1039938Q33398969-ECD16B50-527B-4F91-87C9-C854A28A9290Q33597837-80966F4B-A519-4828-9051-830168433431Q33622816-DC110578-05B4-4F0C-90DE-D1269A049CD6Q33696404-FF907062-6116-4074-A7FD-7CFD1D3E0FACQ33977171-69D71BCA-9D09-43CF-B090-D29FE8FE8725Q34074069-96A26B5C-C4AE-4299-ADE3-3F74554905B5Q34098609-F9F4FF6C-C0A5-4661-A6DE-E0E693910C81Q34602296-77C159FE-6763-4522-BC4F-CE2A920C8303Q34629377-6D50DB7B-8B24-4B9F-A9E9-442FEB1B5826Q35124985-0F75C312-2D46-4709-98A5-2E3DC8E2CE4DQ35607681-ACA44E99-3FC7-41D4-9D9F-3791C148E11EQ35820911-E870B037-C0E0-40AE-8DC3-58F26608EE29Q35947011-F1A29CB6-C4A5-4876-95EE-777C3CDB0CAEQ36053164-BAE9EA21-4B43-4761-AB32-864227B2187EQ36150175-9B99B80E-FF04-4F6A-B0A6-BEAAB9B07612Q36196984-FBCB21E0-206E-436F-8D53-929F47437BABQ36397621-2CCAF6EE-0131-4311-987A-C31FFC586F07Q36718761-C0588650-6576-4FBE-A544-1FC5E6D50144Q36824178-1FE0BF05-4181-47F0-AA81-D8FFA3762D80Q37009026-DF5AB8D5-A089-488D-8DBB-3DD8E81A7185Q37107266-7FD90FBF-E5F3-48FC-9C94-5BD2BBDCF360Q37343420-DCD84F4B-A601-4B57-BD8B-1B4D2CA10777Q37386605-3AD3ACB3-ED8F-413A-B8D8-AE7F912D7A94Q37440707-B4FE729E-B430-4610-9139-403F33BC3C54Q37551744-C2578773-84F2-4C21-BA0C-57A50EC4E6B3Q37669928-321BC42C-397D-496C-A847-CAB4EB3FF750Q37747311-75291021-4809-449D-BD58-AAE0FA8D7E0DQ38007943-174FF877-A97D-4339-8923-20F88C814A1CQ38546730-B0C37091-1242-448A-8DA1-FEBD0446CDFBQ38707365-E95B704B-557C-4678-AB88-BA567E2883FBQ39167413-C44F43BF-1DB2-4408-BF39-721554DEDEA0Q39604716-99786CD1-4F8A-41EA-B3E5-D989CDB3FDCFQ42627555-6408F4E6-867B-4C4D-99C8-1A36A2CDC30AQ42692482-62EFD67A-653D-4D7A-BACF-56A41B3AD56A
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Improved survival in resected biliary malignancies.
@ast
Improved survival in resected biliary malignancies.
@en
Improved survival in resected biliary malignancies.
@nl
type
label
Improved survival in resected biliary malignancies.
@ast
Improved survival in resected biliary malignancies.
@en
Improved survival in resected biliary malignancies.
@nl
prefLabel
Improved survival in resected biliary malignancies.
@ast
Improved survival in resected biliary malignancies.
@en
Improved survival in resected biliary malignancies.
@nl
P2093
P356
P1433
P1476
Improved survival in resected biliary malignancies.
@en
P2093
Attila Nakeeb
Beth A Erickson
Edward J Quebbeman
Henry A Pitt
Khoi Q Tran
Kulwinder S Dua
Michael J Black
Michael J Demeure
Paul S Ritch
Stuart D Wilson
P304
555-63; discission 563-4
P356
10.1067/MSY.2002.127555
P407
P577
2002-10-01T00:00:00Z